Hydrocolloid dressing for eyelid and facial reconstruction wounds
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
NA · University of Kentucky · NCT07075159
This will test whether a thin DuoDERM hydrocolloid dressing applied after Mohs or oculofacial reconstructive surgery can replace daily antibiotic ointment and make post-operative wound care easier for adult patients.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Kentucky (other) |
| Locations | 1 site (Lexington, Kentucky) |
| Trial ID | NCT07075159 on ClinicalTrials.gov |
What this trial studies
This interventional protocol applies a DuoDERM Extra Thin hydrocolloid dressing immediately after Mohs micrographic surgery or oculofacial reconstructive procedures and removes it at the one-week post-operative visit. Patients will return for follow-up visits at 1 week, 6 weeks, and 3 months to document healing, complications, and any need for additional wound care. The approach aims to eliminate routine antibiotic ointment use and reduce the burden of daily wound care on patients. Eligible adults must be able to give informed consent and attend scheduled clinic visits, while those with specified material allergies, impaired consent capacity, or incarceration are excluded.
Who should consider this trial
Good fit: Adults aged 18–100 undergoing Mohs micrographic surgery or oculofacial reconstruction at the enrolling center who can provide informed consent and attend follow-up visits are ideal candidates.
Not a fit: Patients under 18, those allergic to pectin, gelatin, or sodium carboxymethylcellulose, individuals with impaired consent capacity, and incarcerated people are unlikely to be eligible or receive benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could reduce daily wound care tasks and clinic burden while maintaining similar healing and complication rates.
How similar studies have performed: Hydrocolloid dressings have been used successfully in other dermatologic and surgical wound settings, though their immediate post-operative use specifically for oculofacial and Mohs reconstruction is less well studied.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>18 years of age * follow-up at specified intervals (1 week/6 week/3 months) in an office setting * can give informed consent * no patients will be excluded on the basis of gender, ethnicity, or religious background Exclusion Criteria: * Patients \<18 years of age or \>100 * allergy to pectin, gelatin, and sodium carboxymethylcellulose * adults with impaired consent capacity * incarcerated individuals.
Where this trial is running
Lexington, Kentucky
- University of Kentucky — Lexington, Kentucky, United States (RECRUITING)
Study contacts
- Principal investigator: Janice Hernandez, MD — University of Kentucky
- Study coordinator: Connie Dampier
- Email: dampier@uky.edu
- Phone: 859-562-0750
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Wound Healing, Mohs Micrographic Surgery, Oculofacial Reconstruction